Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
North Carolina – Regional Life Sciences Roundup -October 23th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Read More →North Carolina – Regional Life Sciences Roundup – November 6, 2026 North Carolina’s life sciences news this week puts the capacity to do the work alongside the science itself. Progress depends on more than the next development milestone. It also takes funding to sustain the work and experienced people to keep facilities running. That connection […]
A nearly decade-long Biogen engineer steps into a new leadership role at the company’s Research Triangle Park manufacturing site. Lynsey Copley has been named Associate Director, Facilities Engineering at Biogen’s Research Triangle Park, North Carolina site, starting in October 2026. The role marks her latest step in a career of more than nine years at […]
Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second half of 2027
The Foundation's CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis and glioblastoma subtype characterization in a single assay
Appointment of distinguished oncology leaders comes as Incyclix prepares for a potential pivotal trial in 2027
Collaboration pairs tissue and blood samples from disease-specific populations with patient outcomes data to power Network Bio’s foundation models for diagnostics and drug discovery
First-of-its-kind platform and streamlined operating model strengthen Premier’s ability to help healthcare providers reduce costs, improve quality, enhance financial performance and accelerate research.
[Announcement text for desktop] [Shorter announcement text for mobile] Learn more
Durham, North Carolina, 05 November 2026 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced a $100 million, three-year commitment through its U.S.
